Filing Details

Accession Number:
0001181431-14-007781
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-19 19:25:17
Reporting Period:
2014-02-14
Filing Date:
2014-02-19
Accepted Time:
2014-02-19 19:25:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1453814 Medidata Solutions Inc. MDSO Services-Prepackaged Software (7372) 522319066
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1560574 Eileen Schloss C/O Medidata Solutions, Inc.,
350 Hudson Street, 9Th Floor
New York NY 10014
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-02-14 9,130 $58.39 55,956 No 4 F Direct
Common Stock Acquisiton 2014-02-14 6,254 $18.76 62,210 No 4 M Direct
Common Stock Disposition 2014-02-14 6,254 $58.31 55,956 No 4 S Direct
Common Stock Disposition 2014-02-19 10,593 $62.21 45,363 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to buy) Disposition 2014-02-14 6,254 $0.00 6,254 $18.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
68,746 2022-10-29 No 4 M Direct
Footnotes
  1. Shares withheld by Medidata to satisfy the tax withholding obligation in connection with the vesting of previously awarded restricted stock and performance-based restricted stock unit awards.
  2. Such transaction was executed in multiple trades at prices ranging from $62.19 to $62.27. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. The options vested as to 25% of the shares on October 29, 2013 and 1/36th of the remaining options will become exercisable each month thereafter for the next 36 months.